Does transport to primary angioplasty reduce the combined clinical end-point of death, reinfarction, or stroke at 30 days in patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory compared to immediate thrombolysis?
Transferring patients with acute myocardial infarction from community hospitals to tertiary centers for primary angioplasty is safe and significantly reduces the 30-day composite of death, reinfarction, or stroke compared to onsite thrombolysis.
Transferring patients from community hospitals to a tertiary angioplasty centre in the acute phase of myocardial infarction is feasible and safe. This strategy is associated with a significant reduction in the incidence of reinfarction and the combined clinical end-point of death/reinfarction/stroke at 30 days when compared to standard thrombolytic therapy at the community hospital.
Petr Widimský (2000) studied this question.